一心堂药业集团股份有限公司关于使用部分暂时闲置自有资金进行现金管理的进展公告

Group 1 - The company has approved the use of up to RMB 2.5 billion of temporarily idle self-owned funds for cash management, which includes investments in fixed-income or capital-protected financial products, large deposits, and time deposits [1] - The company has signed contracts with Guangfa Bank and Huaxia Bank for structured deposit products as part of its cash management strategy [2] - The cash management investments are considered low-risk, but they are subject to market fluctuations and economic conditions, which may affect short-term returns [2][3] Group 2 - The cash management strategy aims to improve the efficiency of idle funds and generate investment returns, ultimately enhancing the company's overall performance and shareholder value [4] - The company emphasizes prudent investment principles to ensure the safety of funds, stating that cash management will not interfere with normal business operations or the execution of investment projects [4] - The company will conduct internal audits and monitoring of cash management investments to mitigate risks and ensure compliance with relevant regulations [3][4]